In oncolytic virus (OV) therapy, a critical component of tumor immunotherapy, viruses selectively infect, replicate within, and eventually destroy tumor cells. Simultaneously, this therapy activates immune responses and mobilizes immune cells, thereby eliminating residual or distant cancer cells. However, because of OVs' high immunogenicity and immune clearance during circulation, their clinical applications are currently limited to intratumoral injections, and their use is severely restricted. In recent years, numerous studies have used nanomaterials to modify OVs to decrease virulence and increase safety for intravenous injection. The most commonly used nanomaterials for modifying OVs are liposomes, polymers, and albumin, because of their biosafety, practicability, and effectiveness. The aim of this review is to summarize progress in the use of these nanomaterials in preclinical experiments to modify OVs and to discuss the challenges encountered from basic research to clinical application.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690878 | PMC |
| http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0275 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer.
Mol Ther Oncol
December 2024
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Systemic administration of oncolytic viruses (OVs) is a promising approach for targeting metastatic solid tumors, but their anti-tumor activity is limited by pre-existing neutralizing antibodies against common human viruses. Therefore, investigators have developed OVs derived from non-human host viruses. Successful implementation of this strategy requires that the viral vector selectively infects and replicates within human cancer cells.
View Article and Find Full Text PDFOncolytic virus and CAR-T cell therapy in solid tumors.
Front Immunol
November 2024
Dipartimento di Medicina e Chirurgia Traslazionali, Sezione di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
Adoptive immunotherapy with T cells, genetically modified to express a tumor-reactive chimeric antigen receptor (CAR), is an innovative and rapidly developing life-saving treatment for cancer patients without other therapeutic opportunities. CAR-T cell therapy has proven effective only in hematological malignancies. However, although by now only a few clinical trials had promising outcomes, we predict that CAR-T therapy will eventually become an established treatment for several solid tumors.
View Article and Find Full Text PDFOncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients.
Front Immunol
November 2024
Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Oncolytic virotherapy represents an innovative and promising approach for the treatment of cancer, including multiple myeloma (MM), a currently incurable plasma cell (PC) neoplasm. Despite the advances that new therapies, particularly immunotherapy, have been made, relapses still occur in MM patients, highlighting the medical need for new treatment options. Oncolytic viruses (OVs) preferentially infect and destroy cancer cells, exerting a direct and/or indirect cytopathic effect, combined with a modulation of the tumor microenvironment leading to an activation of the immune system.
View Article and Find Full Text PDFNew chitosan schiff base-modified ferrite: Mechanistic insights and performance enhancement in photocatalysis and antibacterial applications.
Int J Biol Macromol
December 2024
Postgraduate Department of Chemistry, Government Postgraduate College Rajouri, Jammu and Kashmir 185131, India; Higher Education Department, Government of Jammu and Kashmir, Jammu 180001, India. Electronic address:
Harnessing biocompatibility and magnetic separability a Chitosan Schiff base-modified ferrite is an innovative approach for addressing the issue of environmental pollution. This study aims to use a new visible light-activated photocatalyst made of cobalt ferrite (CoFe) anchored with Chitosan Schiff Base (CSB) to examine Rhodamine B (RhB) photodegradation. CSB@CoFe composite was synthesized using hydrothermal and sol-gel methods.
View Article and Find Full Text PDFExperimental study on enrichment of heavy metals by modified mullite during co-combustion of lignite with eucalyptus wood.
Environ Technol
October 2024
School of Electric Power, South China University of Technology, Guangzhou, People's Republic of China.
Modifying the content of oxygen vacancies (OVs) has emerged as a crucial approach to tailoring silicate's adsorption properties, microstructure, conductivity, and catalytic performance. Some studies have reported the formation of OVs during ammonia treatment. However, there are limited studies on the production of OV-enriched mullite by treating it with N-containing compounds at low temperatures.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!